A clinical communication tool for the assessment of psychotropic medication side effects

Research output: Contribution to journalArticlepeer-review

11 Citations (Web of Science)


© 2015 Elsevier Ireland Ltd. The primary aim was to assess usability of the My Medicines and Me Questionnaire (M3Q) as a self-reported questionnaire for mental health patients to subjectively express side effects experienced with their psychotropic medications. The secondary aim was to evaluate patients' attitudes towards treatment and psychotropic medications following dialogue with their clinicians about side effects. Questionnaires were administered at six adult mental health facilities. A total of 205 participants were divided into intervention (facilitated dialogue) and non-intervention groups (no facilitated dialogue). The mean completion time for the M3Q was 15. min (SD=6.5) with only 11 (5%) patients requiring assistance. The most commonly reported side effect was sedation (77%) and weight gain was ranked as the most bothersome (23%). The previously validated M3Q provided patients with the opportunity to express the impact these effects had on their lives. Side effects were the most common reason given for non-adherence. There were no significant changes in patient attitudes towards treatment and medications in the intervention group, mainly due to the logistical challenges in the clinicians' ability to view the questionnaire for the subsequent meeting with the patient. The M3Q demonstrated its usability in allowing patients to easily express their subjective experiences with side effects.
Original languageEnglish
Pages (from-to)643-657
JournalPsychiatry Research
Issue number2
Publication statusPublished - 2015


Dive into the research topics of 'A clinical communication tool for the assessment of psychotropic medication side effects'. Together they form a unique fingerprint.

Cite this